missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Isoquinolines and derivatives
  7. ACT 335827, Tocris Bioscience™

ACT 335827, Tocris Bioscience™

Product Code. 30002049
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Potent and selective OX1 antagonist

Potent and selective orexin OX1 receptor antagonist (Kb values are 41 and 560 nM for OX1 and OX2 receptors respectively). Elicits anxiolytic effects in vivo. Brain penetrant and orally available.

Chemical Identifiers

CAS 1354039-86-3
Molecular Formula C31H38N2O5
Molecular Weight (g/mol) 518.654
InChI Key HXHOBPVRRPCTLG-SETSBSEESA-N
Synonym compound 9 pmid: 23589487, 2r-2-1s-1-3,4-dimethoxyphenyl methyl-6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl-2-phenyl-n-propan-2-ylacetamide, ar,1s-1-3,4-dimethoxyphenyl methyl-3,4-dihydro-6,7-dimethoxy-n-1-methylethyl-a-phenyl-2 1h-isoquinolineacetamide, r-2-s-1-3,4-dimethoxybenzyl-6,7-dimethoxy-3,4-dihydroisoquinolin-2 1h-yl-n-isopropyl-2-phenylacetamide
PubChem CID 54765113
IUPAC Name (2R)-2-[(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl]-2-phenyl-N-propan-2-ylacetamide
SMILES CC(C)NC(=O)C(C1=CC=CC=C1)N2CCC3=CC(=C(C=C3C2CC4=CC(=C(C=C4)OC)OC)OC)OC

Specifications

Quantity 50 mg
Formula Weight 518.64
Chemical Name or Material ACT 335827
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.